Pyronaridine
- Generic Name
- Pyronaridine
- Drug Type
- Small Molecule
- Chemical Formula
- C29H32ClN5O2
- CAS Number
- 74847-35-1
- Unique Ingredient Identifier
- TD3P7Q3SG6
- Background
Pyronaridine has been investigated for the treatment of Malaria.
- Indication
本品用于治疗脑型、凶险型及耐氯喹虫珠所致的恶性疟，也用于治疗间日疟。
- Associated Conditions
- Acute Falciparum Malaria, Acute Malaria caused by plasmodium vivax
Human Mass Balance Study of Pyronaridine
- First Posted Date
- 2011-06-28
- Last Posted Date
- 2022-01-26
- Lead Sponsor
- Medicines for Malaria Venture
- Target Recruit Count
- 6
- Registration Number
- NCT01383109
- Locations
- 🇨🇭
Covance Clinical Research Unit AG, Allschwil, Basel, Switzerland
Bioequivalence Trial of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference Tablet
- Conditions
- Malaria
- Interventions
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- Medicines for Malaria Venture
- Target Recruit Count
- 42
- Registration Number
- NCT00682630
- Locations
- 🇨🇭
Cross Research S.A., Phase I Unit, Arzo, Switzerland
Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
- Conditions
- Malaria
- Interventions
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Medicines for Malaria Venture
- Target Recruit Count
- 535
- Registration Number
- NCT00541385
- Locations
- 🇧🇫
Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso
🇨🇩Ecole de Santé Publique, Faculté de Médecine, Université de Kinshasa, Kinshasa, Congo, The Democratic Republic of the
🇨🇮Unité de Paludologie de l'Institut Pasteur d'Abidjan, Abidjan, Côte D'Ivoire
Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria
- First Posted Date
- 2007-02-27
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Medicines for Malaria Venture
- Target Recruit Count
- 456
- Registration Number
- NCT00440999
- Locations
- 🇹🇭
MaeLamad District Hospital, Mae Ramat, Tak Province, Thailand
🇹🇭MaeSod General Hospital, Mae Sot, Tak Province, Thailand
🇰🇭Pailin Referral Hospital, Pailin, Pailin Province, Cambodia
Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients
- Conditions
- Malaria
- Interventions
- First Posted Date
- 2007-01-15
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Medicines for Malaria Venture
- Target Recruit Count
- 1272
- Registration Number
- NCT00422084
- Locations
- 🇨🇩
Ecole de Santé Publique, Faculté de Médecine, Université de Kinshasa, Kinshasa, Congo, The Democratic Republic of the
🇬🇲Farafenni Field Station, c/o: MRC Laboratories, Fajara, Gambia
🇬🇭Komfo Anoykye Teaching Hospital, Kumasi, Ghana
Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients
- Conditions
- Falciparum Malaria
- Interventions
- First Posted Date
- 2006-11-23
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Medicines for Malaria Venture
- Target Recruit Count
- 1271
- Registration Number
- NCT00403260
- Locations
- 🇧🇫
RAOTAP2/Centre Muraz, Bobo Dioulasso, Houet Province, Burkina Faso
🇮🇳Wentlock District Hospital, Mangalore, India
🇨🇮Institut Pasteur, Abidjan, Côte D'Ivoire
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.